Cargando…
USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels
INTRODUCTION: The hyperactivation of receptor tyrosine kinase (RTK)-mediated pathways plays an important role in melanoma progression and resistance to therapy. The ubiquitin-specific protease 8 (USP8) is a deubiquitinating enzyme and its inhibition induces degradation of RTKs. This work explored th...
Autores principales: | Duan, Baoxue, Wang, Changying, Liu, Zeng, Yang, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163583/ https://www.ncbi.nlm.nih.gov/pubmed/34079371 http://dx.doi.org/10.2147/CMAR.S300195 |
Ejemplares similares
-
Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases
por: Zhu, Ying, et al.
Publicado: (2021) -
EGF receptor kinase suppresses ciliogenesis through activation of USP8 deubiquitinase
por: Kasahara, Kousuke, et al.
Publicado: (2018) -
Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma
por: Crose, Lisa E. S., et al.
Publicado: (2011) -
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto, Ross A, et al.
Publicado: (2015) -
Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
por: Roesler, Rafael, et al.
Publicado: (2021)